Inflammatory bowel diseases (IBD) increase the risk of developing colorectal cancer.
INTRODUCTION
Individuals with inflammatory bowel disease (IBD) have an increased risk of developing colon cancer. Colorectal cancer is responsible for mortality in approximately 15% of people with ulcerative colitis and Crohn's disease (1) . Despite routine screening procedures and the development of advanced treatments, one third of patients with colon cancer will ultimately experience metastatic disease and most will die of uncontrolled metastasis within a few years of diagnosis (2) . In contrast to colon polyps which can be easily detected via colonoscopy, chronic colitis can result in dysplastic lesions that are difficult to identify. Flat colorectal adenoma is associated with accelerated carcinogenesis (3, 4) and poor prognosis (5) . Given the negative outcome linked with colitis-associated colon cancer (CACC), prevention strategies aimed at reducing inflammation in individuals with IBD may reduce cancer risk.
Several studies have demonstrated efficacy of dietary fish oil (FO) consumption in IBD (6) (7) (8) (9) (10) . Long chain omega-3 polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (DHA) and ecosapentaenoic acid (EPA), modulate inflammatory responses through several mechanisms. Increased consumption of dietary DHA and EPA results in increased incorporation of these n-3 fatty acids in immune cell membranes and occurs at the expense of arachidonic acid (11) (12) (13) . Specifically, EPA can compete with arachidonic acid as a substrate for cyclooxygenase (COX) resulting in inhibition of the production of pro-inflammatory eicosanoids such as prostaglandin E2 (PGE2) and leukotriene B4 Increased membrane PUFA content also influences lipid raft composition and signaling properties of immune cells (14) . DHA is capable of influencing membrane fluidity, ion permeability, fatty acid exchange, and resident protein function (14, 15) .
6 Bacterial culture and infection. H. hepaticus strain 3B1 (ATCC 51488) was kindly donated by Dr. Vince Young (University of Michigan). Isolates were aseptically streaked onto blood agar and incubated at 36˚C for 24-48 hrs inside GasPak™ (BD Diagnostic Systems, Sparks, MD).
Mice were infected as previously described (21). Briefly, bacteria were resuspended in tryptic soy broth at an optical density ≥ 1.8. Animals were gavaged with 0.3 mL of fresh bacterial suspension on two consecutive days.
Experimental Design. Three separate diet studies were performed. In study 1, male and female mice were fed either Harlan Teklad rodent chow (CON), CO, SF, or 6.00% DFO for 8 wks preinfection. In study 2, mice received either SF, or DFO (0.75, 2.25, 3.75, or 6.00%;n=16-20 mice/treatment). Mice consumed the assigned diet for 8 wks prior to infection and throughout 4 wks post-infection when the experiment was terminated. For study 3, mice were fed either 6.00% DFO or CON and euthanized. See Table 1 for fatty acid composition of the diets.
Tissue fixation and histopathology. Mice were asphyxiated with CO 2 and exsanguinated via cardiac puncture. Tissue was removed, flushed with phosphate buffered saline (PBS) and fixed in 10% formalin overnight and stored in 70% ethanol. Tissues were then processed in paraffin and stained with hematoxylin and eosin (H&E). Longitudinal sections were graded for inflammation and dysplasia by pathologist using a blinded scoring system adapted from Dr.
Maggio-Price (21). Cecums and colons were scored on a 1 to 4 scale both for inflammation (1, no inflammation; 2, mild inflammation; 3, moderate inflammation; 4, marked inflammation) and dysplasia (1, no dysplasia; 2, low grade dysplasia; 3, high grade dysplasia; 4, high grade dysplasia with invasion/adenocarcinoma). The two scores for colon and two scores for cecum tissue in each animal were combined such that a score of 4 indicated no inflammation or dysplasia and a score of 16 reflected maximal inflammation and dysplasia.
7
Tissue Fatty Acid Analysis. To confirm DHA phospholipid incorporation after 8 wks of DFO consumption, hepatic lipid fractions were extracted and analyzed by gas chromatography (GC) as previously described (33, 34) .
Lymphocyte isolation. Spleens (Spln) and mesenteric lymph nodes (MsLn) were aseptically removed and placed in ice cold RMPI at the time of necropsy. Spleens were processed with a dounce homogenizer, pelleted, and washed in RPMI. Cells were resuspended in ACK lysing buffer (Invitrogen, Carlsbad, CA) and washed twice in RPMI. MsLn were passed through a 70 µm filter and washed with RPMI. Cell counts were performed with a hemocytometer using trypan blue exclusion and resuspended to a concentration of one million cells per mL of media. Statistics. Data analysis was performed using GraphPad Prism (GraphPad Software, La Jolla, CA). All data were represented as mean ± SEM. Two-way ANOVA were performed with 
RESULTS

DFO-fed mice displayed increased intestinal inflammation and dysplasia following
infection with H. hepaticus. Unexpectedly, we found that 4 wks post-infection mice consuming 6.00% DFO had the highest degree of inflammation and dysplasia compared to the three control diets (CO, SF, and chow (CON) (Fig. 1) . The observed exacerbation in colitis was dosedependent as the 2.25% and 3.75% DFO groups received a score falling between the 6.00% DFO and the three controls; however, the difference in histopathology scores between these was not statistically significant. The 0.75% DFO group was not different from the control groups, however it was significant when compared with the 6.00% DFO. Since no significant differences in colitis scores were found between the three control groups, the chow diet was selected as a control for all remaining experiments.
Representative H&E stains of colon and cecum tissue demonstrated a greater number of inflammatory cells as well as epithelial proliferative lesions at 4 weeks post infection as DFO composition increased (Fig. 2) . The control CO and SF-fed mice displayed increased inflammatory cell infiltration and mild hyperplasia in the mucosa of both the cecum and colon.
These observations were expected in SMAD3-/-mice in response to infection with H. hepaticus.
However, DFO fed mice had an even greater severity of inflammation accompanied by dysplastic crypts and mitotic figures (Fig. 2) .
To confirm the presence of DHA in cellular phospholipids, hepatic fatty acids from CON, SF, and DFO-fed animals were extracted and analyzed by GC. As expected, mice consuming 6% DFO feeding increased post-infection mortality and body mass loss. Mice consuming DFO had a higher mortality rate following infection with H. hepaticus compared to the control diets (CON, CO, SF) (Fig. 3A) . All mice in the CON and CO groups and 92% of mice on the SF diet survived following infection with H. hepaticus. However, only 82% of DFO-fed animals survived 4 weeks, with mortality in this group observed as early as 1 week post infection (PI).
The cause of mortality in the DFO group was not further investigated as this was an unexpected finding. However, we did observe that animals in this group gained less weight from wks 0 to 4 after infection compared with CO or SF-fed counterparts (Fig. 3B ). These weight changes were in accordance with survival data through wk 4.
DFO feeding modulated CD4+ and CD8+ T cell populations in SMAD3-/-mice. The total
cell counts in each group did not significantly differ within either tissue (data not shown). CON treatment induced kinetic differences across time in CD3+ cells whereas DFO did not. Note the difference in CD3+ lymphocytes at day 3 PI in MsLn of DFO-treated animals (p<0.05; Figure   4A ). DFO induced potent reductions in the proportion of CD8+CD3+ cells in both tissues prior to gavage and throughout infection ( figure 4A ). In addition, DFO-fed animals exhibited increased CD4+CD3+ splenic T lymphocytes prior to infection and at day 7 (p<0.001; Figure   4A ). However, no differences were noted in the MsLn. DFO resulted in greatly decreased percentages of CD4+ T cells from the MsLn expressing CD69 ( Figure 4B ).
Regulatory T cell populations and FoxP3 expression were altered by DFO feeding. The
proportion of FoxP3+ CD25+ T cells within the CD4+ T cell population was significantly increased in the spleen in response to DFO feeding both before infection (p<0.05) and at days The dose of FO, relative EPA and DHA content, and length of feeding protocol are also another source of variation. In our study, the most severe colitis and CACC correlated with the 6.00% DFO dose for a feeding period of 8 wks (Fig. 1 ). The dietary composition and feeding period are comparable to other FO feeding studies with the exception that our DFO contained mostly DHA and only little EPA. Interestingly, we observed low dose (0.75%) DFO consumption did not ameliorate colitis score compared to control animals (SF, CO, and CON).
Furthermore, animals consuming intermediate doses of DFO (2.25% and 3.75%) experienced exacerbated inflammation and dysplasia that was comparable to the 6.00% DFO diet ( Fig. 1 and   2 ). Our results indicate DFO consumption as low as 2.25% aggravates colitis and accelerates dysplastic tissue transformation.
Due to the potential role of impaired TGF-β signaling in Treg cell response, we hypothesized DHA feeding may further influence Treg cell populations. Not only did DFO-fed mice exhibit a high proportion of splenic CD4+ T cells, but a higher percentage of this population was also FoxP3+ CD25+ (Fig. 5 ). This suggests that dietary DFO may be inducing a more pronounced splenic Treg cell phenotype both under pathogen-free conditions and during infection. Interestingly, although no difference was found in FoxP3+CD25+ populations in the MsLn, FoxP3 expression (MFI) was enhanced in both spleen and MsLn in DFO-fed mice (Table   2 ). No statistical differences were found when 2.25% and 3.75% were compared to 6.00%. 2 inflamed (*). DFO, 6.00%. The tunica muscularis of the cecum is multifocally disrupted by an adenocarcinoma, composed of single or nests of crypts lined by relatively well differentiated epithelium (arrows) and lakes of mucin that extend into and beyond the serosal lining (*). In the colon, the wall is thickened due to moderate inflammation and hyperplastic crypts (arrow) that occasionally herniate into the submucosa (*). 
